Patents by Inventor Pierre-Yves Bounaud

Pierre-Yves Bounaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hedgehog inhibitors
    Patent number: 9174949
    Abstract: Described herein are compounds, pharmaceutical compositions and methods for the inhibition of Hedgehog signaling. Said compounds, pharmaceutical compositions and methods have utility in the treatment of human and veterinary disease and disorders.
    Type: Grant
    Filed: January 6, 2011
    Date of Patent: November 3, 2015
    Assignee: SELEXAGEN THERAPEUTICS, INC.
    Inventors: Jean-Michel Vernier, John May, Patrick O'Connor, William Ripka, Anthony Pinkerton, Pierre-Yves Bounaud, Stephanie Hopkins
  • RAF KINASE INHIBITORS
    Publication number: 20140221374
    Abstract: Described herein are compounds, pharmaceutical compositions and methods for the inhibition of RAF kinase mediated signaling. Said compounds, pharmaceutical compositions and methods have utility in the treatment of human disease and disorders.
    Type: Application
    Filed: March 16, 2012
    Publication date: August 7, 2014
    Applicant: Ruga Corporation
    Inventors: Jean-Michel Vernier, Stephanie Hopkins, Pierre-Yves Bounaud, Patrick O'Connor, David Matthews, Steve Bender
  • LRRK2 INHIBITORS
    Publication number: 20140205537
    Abstract: Provided herein are compounds that inhibit or partially inhibit the activity of leucine rich repeat kinases. Also provided herein are methods of treatment of CNS disorders comprising administration of inhibitors of leucine rich repeat kinases.
    Type: Application
    Filed: June 22, 2012
    Publication date: July 24, 2014
    Applicant: ZENOBIA THERAPEUTICS, INC.
    Inventors: Pierre-Yves Bounaud, Vicki Nienaber, Ruo W. Steensma, John A. Lowe, III
  • Bicyclic triazoles as protein kinase modulators
    Patent number: 8507489
    Abstract: The present disclosure provides bicyclic triazole protein kinase modulators and methods of using these compounds to treat diseases mediated by kinase activity.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: August 13, 2013
    Assignee: SGX Pharmaceuticals, Inc.
    Inventors: Pierre-Yves Bounaud, Christopher Ronald Smith, Elizabeth Anne Jefferson
  • RAF KINASE INHIBITORS
    Publication number: 20130040983
    Abstract: Described herein are compounds, pharmaceutical compositions and methods for the inhibition of RAF kinae mediated signaling. Said compounds, pharmaceutical compositions and methods have utility in the treatment of human disease and disorders.
    Type: Application
    Filed: January 7, 2011
    Publication date: February 14, 2013
    Inventors: Jean-Michel Vernier, Patrick O'Connor, William Ripka, David Matthews, Anthony Pinkerton, Pierre-Yves Bounaud, Stephanie Hopkins
  • HEDGEHOG INHIBITORS
    Publication number: 20130012513
    Abstract: Described herein are compounds, pharmaceutical compositions and methods for the inhibition of Hedgehog signaling. Said compounds, pharmaceutical compositions and methods have utility in the treatment of human and veterinary disease and disorders.
    Type: Application
    Filed: January 6, 2011
    Publication date: January 10, 2013
    Inventors: Jean-Michel Vernier, John May, Patrick O'Connor, William Ripka, Anthony Pinkerton, Pierre-Yves Bounaud, Stephanie Hopkins
  • Triazolopyridazine protein kinase modulators
    Patent number: 8071581
    Abstract: The present disclosure relates to triazolopyridazine protein kinase modulators of Formula (I), methods of using these compounds to treat diseases mediated by kinase activity.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: December 6, 2011
    Assignee: SGX Pharmaceuticals, Inc.
    Inventors: Christopher Ronald Smith, Pierre-Yves Bounaud, Elizabeth Anne Jefferson, Patrick S. Lee, Eduardo Torres
  • BICYCLIC PYRAZOLO PROTEIN KINASE MODULATORS
    Publication number: 20100179190
    Abstract: The present invention provides novel bicyclic pyrazolo kinase modulators and methods of using the novel bicyclic pyrazolo kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: November 14, 2008
    Publication date: July 15, 2010
    Applicant: SGX PHARMACEUTICALS, INC.
    Inventors: Pierre-Yves Bounaud, Andrew Vaino
  • TRIAZOLOPYRIDAZINE PROTEIN KINASE MODULATORS
    Publication number: 20100120739
    Abstract: The present disclosure relates to triazolopyridazine protein kinase modulators of Formula (I), methods of using these compounds to treat diseases mediated by kinase activity.
    Type: Application
    Filed: October 18, 2007
    Publication date: May 13, 2010
    Inventors: Christopher Ronald Smith, Pierre- Yves Bounaud, Elizabeth Anne Jefferson, Patrick S. Lee, Eduardo Torres
  • BICYCLIC TRIAZOLES AS PROTEIN KINASE MODULATORS
    Publication number: 20090258855
    Abstract: The present disclosure provides bicyclic triazole protein kinase modulators and methods of using these compounds to treat diseases mediated by kinase activity.
    Type: Application
    Filed: October 18, 2007
    Publication date: October 15, 2009
    Inventors: Pierre-Yves Bounaud, Christopher Ronald Smith, Elizabeth Anne Jefferson
  • Pyrrolo-pyridine kinase modulators
    Patent number: 7601839
    Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: October 13, 2009
    Assignee: SGX Pharmaceuticals Inc.
    Inventors: William D. Arnold, Pierre-Yves Bounaud, Andreas Gosberg, Zhe Li Bounaud, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
  • Pyrrolo-pyridine kinase modulators
    Patent number: 7582637
    Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: September 1, 2009
    Assignee: SGX Pharmaceuticals, Inc.
    Inventors: William D. Arnold, Pierre-Yves Bounaud, Andreas Gosberg, Zhe Li Bounaud, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
  • HETEROCYCLIC KINASE MODULATORS
    Publication number: 20090156594
    Abstract: The present disclosure provides heterocyclic protein kinase modulators and methods of using these compounds to treat diseases mediated by kinase activity.
    Type: Application
    Filed: May 21, 2008
    Publication date: June 18, 2009
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: Pierre-Yves Bounaud, Christopher Ronald Smith, Elizabeth A. Jefferson, Jorg Hendle, Patrick S. Lee, Angelina Marie Thayer, Gavin Charles Hirst
  • Bicyclic pyrazolo protein kinase modulators
    Patent number: 7473783
    Abstract: The present invention provides novel bicyclic pyrazolo kinase modulators and methods of using the novel bicyclic pyrazolo kinase modulators to treat diseases mediated by kinase activity.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: January 6, 2009
    Assignee: SGX Pharmaceuticals, Inc.
    Inventors: Pierre-Yves Bounaud, Andrew Vaino
  • PYRROLO-PYRIDINE KINASE MODULATORS
    Publication number: 20090005378
    Abstract: The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: February 29, 2008
    Publication date: January 1, 2009
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: William D. Arnold, Pierre-Yves Bounaud, Andreas Gosberg, Zhe Li Bounaud, Ian McDonald, Ruo W. Steensma, Mark E. Wilson
  • Pyrazolothiazole Protein Kinase Modulators
    Publication number: 20070173488
    Abstract: The present invention provides pyrazolothiazole kinase modulators, methods of treating certain disease states, such as cancer, and pharmaceutical composition thereof.
    Type: Application
    Filed: November 16, 2006
    Publication date: July 26, 2007
    Applicant: SGX Pharmaceuticals, Inc.
    Inventors: Pierre-Yves Bounaud, Stephanie Hopkins, Elizabeth Jefferson, Mark Wilson, Melissa Wong, Toufike Kanouni
  • Bicyclic pyrazolo protein kinase modulators
    Publication number: 20050176786
    Abstract: The present invention provides novel bicyclic pyrazolo kinase modulators and methods of using the novel bicyclic pyrazolo kinase modulators to treat diseases mediated by kinase activity.
    Type: Application
    Filed: December 17, 2004
    Publication date: August 11, 2005
    Applicant: Structural GenomiX
    Inventors: Pierre-Yves Bounaud, Andrew Vaino
  • Inhibitors of protein kinase for the treatment of disease
    Publication number: 20030187007
    Abstract: The present invention is directed in part towards methods of modulating the function of protein kinases with phenol- and hydroxynaphthalene-based compounds. The methods incorporate cells that express a protein kinase. In addition, the invention describes methods of preventing and treating protein kinase-related abnormal conditions in organisms with a compound identified by the invention. Furthermore, the invention pertains to phenol- and hydroxynaphthalene-based compounds and pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: May 28, 2002
    Publication date: October 2, 2003
    Inventors: Sheldon Xiaodong Cao, Pierre-Yves Bounaud, Xiaohua Chen, Hyun-Ho Chung, Sunil Kumar KC, Changhee Min, Jae Young Yang, Melissa C. Long